May 10, 2018
ERWIN, Tenn. – There's one last hope for Tennesseans who might benefit from a state-of-the-art cancer treatment.
Republican Gov. Bill Haslam vetoed the Cancer Patient Choice Act late last week, but there's talk of a possible special session to override his veto.
May 08, 2018 02:24 PM
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Governor Haslam’s statement regarding his veto of the Proton Therapy Access Act states that the Act “circumvents the established process for determining state employee insurance program coverage based on medical evidence and effectiveness.” According to Don Denton, President, Tennessee Cancer Patient Coalition, “State Executive Director of Benefits Administration, Laurie Lee, testified multiple times that her team lacks the resources and expertise to recommend or review coverage guidelines so they outsource those decisions to their insurance company and their insurer’s utilization manager, eviCore Healthcare Management. So, the established process the Governor refers to is simply outsourcing the decision to a third-party which has a vested interest in rationing healthcare. Relying on insurance companies to establish coverage guidelines for the latest therapies is obviously a flawed process for cancer patients given the disparity between eviCore’s proton therapy guidelines covering less than 5% of cancer incidence while Medicare covers over 70% of cancer incidence. This is clearly the case of the fox watching the hen house.”
NEW ALLIANCE OF CANCER CARE ADVOCATES LAUNCHES NATIONAL CAMPAIGN TO PROMOTE FAIR AND TIMELY ACCESS TO PROTON THERAPY
“Tell Insurers: Fight Cancer, Not Me” campaign issues letters to insurers seeking clarity on current proton therapy coverage policies and approval processes
By Alliance for Proton Therapy Access | July 25, 2017 Read More
News and Press Releases Proton Therapy